Trex Medical completes public offering
X-ray vendor Trex Medical this month completed a public stockoffering that raised net proceeds of $49.8 million. Trex, of Danbury,CT, issued 2.9 million shares of stock at $14 a share, includingan over-allotment option of 375,000 shares. The stock was
X-ray vendor Trex Medical this month completed a public stockoffering that raised net proceeds of $49.8 million. Trex, of Danbury,CT, issued 2.9 million shares of stock at $14 a share, includingan over-allotment option of 375,000 shares. The stock was tradingat about $20 a share in mid-July. Parent company ThermoTrex retainsan 80% stake in Trex Medical.
In other Trex Medical news, the company announced that it hassigned a preferred provider deal to supply mammography and stereotacticbiopsy equipment to the Columbia/HCA hospital chain. Columbia/HCAhospitals will be able to purchase Lorad and Bennett mammographysystems and upright stereotactic biopsy devices, as well as Lorad'sprone stereotactic biopsy table.
The deal puts Trex in privileged company: Columbia/HCA hasa close equipment purchasing relationship with GE Medical Systemsas part of the multivendor service and asset management relationshipbetween the companies (SCAN 3/29/95).
Trex Medical CEO Hal Kirshner also reported that Trex has ambitiousplans for the upcoming Radiological Society of North America meetingin December. The company will use the Trex Medical logo at itsbooth for the first time, with subsidiary companies like Lorad,Bennett, XRE, and Continental occupying separate sections of theexhibit.
"We're going to have a very big booth," Kirshnersaid.
Can MRI-Guided Transurethral Ultrasound Ablation Have an Impact for Localized Prostate Cancer?
December 11th 2023Follow-up MRI imaging one year after transurethral ultrasound ablation revealed approximately 50 percent decreases in prostate volume and median PSA density, according to recently presented research findings at the 2023 Society of Urologic Oncology (SUO) Annual Meeting.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.
